PULSION launches PiCCO2

At the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in March this year, PULSION presented their new product PiCCO2, the first product of a new generation in hemodynamic monitoring. PiCCO2 provides its users with a general overview, as well as detailed insights into the different aspects of the cardio-vascular system through a combination of technologies. Its functions include continuous central venous oxigenation monitoring, volume management, bedside assessment of pulmonary edema, and others, thus aiding the attending physician in making fast and accurate diagnoses and better therapeutic decisions. PiCCO2 is an instrument designed to support the hemodynamic therapy of acute critically ill patients, where optimal oxygenation of the organism is among the principal goals. It is built to meet the need in critical care for early recognition of supply deficiencies and for accurate diagnosis. Bradley Gould, CEO of PULSION Medical Systems AG, said: “We wanted to make a product available to doctors and nursing staff which would, through ease of use, provide maximumsupport for making time sensitive decisisons. The feedback from the public for our groundbreaking new product was overwhelming and I believe that we are hereby also ready for the competition in the US market.”